Landmark TIOSPIRTM trial reinforces importance of SPIRIVA ® in both available formulations as the world's leading maintenance therapy for chronic obstructive pulmonary disease (COPD)

Landmark TIOSPIRTM trial reinforces importance of SPIRIVA ® in both available formulations as the world's leading maintenance therapy for chronic obstructive pulmonary disease (COPD)
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news

Related Links:

Authors: Karloh M, Sousa Matias T, Fleig Mayer A Abstract Social distancing and quarantines have been implemented worldwide to reduce the spread of Coronavirus Disease (COVID-19). However, social distancing has had far-reaching health consequences, considering that the COVID-19 pandemic has exposed people to the hazard of physical inactivity and sedentary behavior. For patients with Chronic Obstructive Pulmonary Disease (COPD), which is one of the main diseases at risk for COVID-19, the impact is even greater since outpatient pulmonary rehabilitation (PR) programs are temporarily closed. More than ever, patients' b...
Source: COPD: Journal of Chronic Obstructive Pulmonary Disease - Category: Respiratory Medicine Tags: COPD Source Type: research
CONCLUSIONS: In the CRCSA cohort from Johannesburg, comorbidity is uncommon, with no significant adverse effect on OS. If potentially curative treatment is initiated within 40 days of CRC diagnosis, OS could be improved. To fully understand the epidemiology of CRC in SA, population-based registries are essential, and future research should aim to identify health system failures that lead to delays in intervention beyond 40 days in patients with CRC. PMID: 32657722 [PubMed - as supplied by publisher]
Source: South African Medical Journal - Category: African Health Tags: S Afr Med J Source Type: research
npj Primary Care Respiratory Medicine, Published online: 14 July 2020; doi:10.1038/s41533-020-0188-9A cohort study of medication adherence among patients with chronic obstructive pulmonary disease in Egypt
Source: npj Primary Care Respiratory Medicine - Category: Primary Care Authors: Source Type: research
The COVID-19 pandemic has led to the implementation and use of telemedicine and telehealth platforms and devices as part of current day-to-day standards of care in many hospital and healthcare systems. In this era of social distancing, doctors on our...
Source: Medgadget - Category: Medical Devices Authors: Tags: Anesthesiology Cardiology Critical Care Diagnostics Education Emergency Medicine Exclusive Geriatrics Informatics Pediatrics Public Health Source Type: blogs
Conclusions: The classification of COPD produced by mMRC, CAT, and CCQ was not identical. Smoking status, underweight, ACO, post-bronchodilator FEV1% predicted #x3c;50%, exacerbation history, and mMRC were associated with lower health-related quality of life assessed by the total CCQ score, while different subdomains of CCQ had different determinant factors.Respiration
Source: Respiration - Category: Respiratory Medicine Source Type: research
Levodopa oral dry powder inhalation (DPI, Inbrija) was recently approved by the United States (US) Food and Drug Administration (FDA) for patients whose current carbidopa/levodopa dose is wearing off prematurely [1]. According to the package insert, inhaled levodopa is not recommended for patients with chronic respiratory diseases, such as asthma and/or chronic obstructive lung disease (COPD), due to risk of bronchospasm [2]. In a study, 25 otherwise healthy adult patients (without Parkinson's Disease (PD)) with mild or moderate asthma received 84 mg of levodopa inhalation powder for 3 doses, separated every 4 hours [2].
Source: Parkinsonism and Related Disorders - Category: Neurology Authors: Tags: Correspondence Source Type: research
AbstractBackgroundMany studies have indicated that S100A8 and S100A9 may be involved in the development and progression of chronic obstructive pulmonary disease (COPD). However, there has been no clinical study analyzing the role of the serum S100A8/S100A9 heterodimer in COPD patients. The aim of this study was to analyze the correlation of the serum S100A8/S100A9 heterodimer with pulmonary function in COPD patients during acute exacerbation (AE-COPD) based on a cross-sectional study.MethodsA total of 131 AE-COPD patients and matched healthy subjects were recruited. Pulmonary function, arterial blood gas values, and serum ...
Source: Lung - Category: Respiratory Medicine Source Type: research
Abstract A systematic review and meta-analysis was conducted in an attempt to systematically collect and evaluate the associations of epidemiological, comorbidity factors with the severity and prognosis of coronavirus disease 2019 (COVID-19). The systematic review and meta-analysis was conducted according to the guidelines proposed by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Sixty nine publications met our study criteria, and 61 studies with more than 10,000 COVID-19 cases were eligible for the quantitative synthesis. We found that the males had significantly higher disease ...
Source: Aging - Category: Biomedical Science Authors: Tags: Aging (Albany NY) Source Type: research
Source: International Journal of COPD - Category: Respiratory Medicine Tags: Clinical Pharmacology: Advances and Applications Source Type: research
Guidelines for chronic obstructive pulmonary disease (COPD) recommend supplementing pharmacotherapy with non-pharmacological interventions. Little is known about the use of such interventions by patients. We analyzed the utilization of a number of non-pharmacological interventions and identified potential determinants of use.
Source: Respiratory Medicine - Category: Respiratory Medicine Authors: Source Type: research
More News: Chronic Obstructive Pulmonary | Research | Spiriva | Tiotropium